Literature DB >> 32885604

Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients.

Zaid Haddadin1, Karen Krueger2, Lora D Thomas3, Edgar T Overton4, Michael Ison5, Natasha Halasa1.   

Abstract

Solid organ transplant (SOT) recipients are at increased risk of influenza disease and associated complications. The mainstay of prevention is the annual standard-dose influenza vaccine, as studies showed decreased influenza-related morbidity and mortality in vaccinated SOT recipients compared to those unvaccinated. Nonetheless, the immune response in this high-risk population is suboptimal compared to healthy individuals. Over the past two decades, several vaccination strategies have been investigated to overcome this inadequate immune response in SOT recipients. Howbeit, the best vaccination strategy and optimal timing of influenza vaccination remain unclear. This review will provide a detailed summary of studies of various influenza vaccination strategies in adult SOT recipients, discussing immunogenicity results, and addressing their limitations and knowledge gaps.
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; editorial/personal viewpoint; immunobiology; infection and infectious agents-viral: influenza; infectious disease; organ transplantation in general; preventive healthcare; vaccine

Mesh:

Substances:

Year:  2020        PMID: 32885604     DOI: 10.1111/ajt.16295

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  10 in total

1.  The future of SARS-CoV-2 vaccines in transplant recipients: To be determined.

Authors:  Emily A Blumberg; Oriol Manuel; Martina Sester; Michael G Ison
Journal:  Am J Transplant       Date:  2021-04-19       Impact factor: 9.369

Review 2.  Preparing for the 2020-2021 influenza season.

Authors:  Annabelle de St Maurice; Rachel Martin-Blais; Natasha Halasa
Journal:  Pediatr Transplant       Date:  2021-04-27

3.  Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients.

Authors:  Monica Miele; Rosalia Busà; Giovanna Russelli; Maria Concetta Sorrentino; Mariangela Di Bella; Francesca Timoneri; Alessandra Mularoni; Giovanna Panarello; Patrizio Vitulo; Pier Giulio Conaldi; Matteo Bulati
Journal:  Am J Transplant       Date:  2021-06-18       Impact factor: 9.369

4.  SARS-CoV-2 Vaccination and Solid Organ Transplant Patients: Data Needed to Inform Safety and Efficacy.

Authors:  Michael G Ison; Robin Avery; Emily Blumberg; Peter Chin-Hong; Natasha Halasa; Dan Kaul; Steve Pergam; Nicole M Theodoropoulos; Cameron R Wolfe
Journal:  Transplantation       Date:  2021-10-01       Impact factor: 5.385

5.  Acute kidney rejection after anti-SARS-CoV-2 virus-vectored vaccine-case report.

Authors:  Matej Vnučák; Karol Graňák; Monika Beliančinová; Miloš Jeseňák; Katarína Kajová Macháleková; Jakub Benko; Matej Samoš; Ivana Dedinská
Journal:  NPJ Vaccines       Date:  2022-03-02       Impact factor: 7.344

6.  Notifiable Infectious Diseases Among Organ Transplant Recipients: A Data-Linked Cohort Study, 2000-2015.

Authors:  Karen M J Waller; Nicole L De La Mata; Kate R Wyburn; James A Hedley; Brenda M Rosales; Patrick J Kelly; Vidiya Ramachandran; Karan K Shah; Rachael L Morton; William D Rawlinson; Angela C Webster
Journal:  Open Forum Infect Dis       Date:  2022-08-03       Impact factor: 4.423

Review 7.  Vaccination in patients with kidney failure: lessons from COVID-19.

Authors:  Nina Babel; Christian Hugo; Timm H Westhoff
Journal:  Nat Rev Nephrol       Date:  2022-08-23       Impact factor: 42.439

8.  Analysis of the Specific Immune Response after the Third Dose of mRNA COVID-19 Vaccines in Organ Transplant Recipients: Possible Spike-S1 Reactive IgA Signature in Protection from SARS-CoV-2 Infection.

Authors:  Monica Miele; Rosalia Busà; Giovanna Russelli; Maria Concetta Sorrentino; Mariangela Di Bella; Francesca Timoneri; Giampiero Vitale; Elisa Calzolari; Patrizio Vitulo; Alessandra Mularoni; Pier Giulio Conaldi; Matteo Bulati
Journal:  Microorganisms       Date:  2022-08-03

9.  SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know?

Authors:  Madeleine R Heldman; Ajit P Limaye
Journal:  J Am Soc Nephrol       Date:  2021-03-24       Impact factor: 10.121

10.  Antibodies, boosters, and optimizing SARS-CoV-2 vaccines for transplantation: A call for more research.

Authors:  Michael G Ison; Emily Blumberg; Natasha Halasa; Dan Kaul; Nicole M Theodoropoulos; Cameron R Wolfe
Journal:  Am J Transplant       Date:  2021-07-26       Impact factor: 9.369

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.